Antitumor Sulfonylhydrazines: Design, Structure–Activity Relationships, Resistance Mechanisms, and Strategies for Improving Therapeutic Utility
Article in Journal of Medicinal Chemistry (February 2015)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine
Article in Molecular and Cellular Biochemistry (August 2012)
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors
Article in International Journal of Radiation Biology (December 2011)